Concord Wealth Partners’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33
| Closed | -$1.22K | – | 867 |
|
|
2025
Q1 | $1.22K | Hold |
33
| – | – | ﹤0.01% | 717 |
|
|
2024
Q4 | $2.83K | Sell |
33
-61
| -65% | -$5.22K | ﹤0.01% | 676 |
|
|
2024
Q3 | $17.5K | Buy |
94
+25
| +36% | +$4.64K | ﹤0.01% | 494 |
|
|
2024
Q2 | $11.7K | Sell |
69
-3
| -4% | -$511 | ﹤0.01% | 490 |
|
|
2024
Q1 | $30.8K | Hold |
72
| – | – | 0.01% | 431 |
|
|
2023
Q4 | $63K | Hold |
72
| – | – | 0.01% | 325 |
|
|
2023
Q3 | $67.3K | Sell |
72
-30
| -29% | -$28.1K | 0.01% | 335 |
|
|
2023
Q2 | $98.1K | Sell |
102
-17
| -14% | -$16.3K | 0.02% | 277 |
|
|
2023
Q1 | $132K | Hold |
119
| – | – | 0.04% | 214 |
|
|
2022
Q4 | $77.7K | Hold |
119
| – | – | 0.02% | 291 |
|
|
2022
Q3 | $100K | Hold |
119
| – | – | 0.03% | 157 |
|
|
2022
Q2 | $103K | Buy |
119
+7
| +6% | +$6.06K | 0.03% | 260 |
|
|
2022
Q1 | $170K | Buy |
112
+27
| +32% | +$41K | 0.04% | 204 |
|
|
2021
Q4 | $106K | Buy |
+85
| New | +$106K | 0.03% | 303 |
|